Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Does celiac disease cause secondary exocrine pancreatic insufficiency by reducing duodenal hormone signaling?

Celiac disease and other small‑intestinal enteropathies can cause secondary exocrine pancreatic insufficiency by impairing duodenal hormone signaling (CCK and secretin) that normally stimulates pancreatic enzyme and bicarbonate secretion.

PlausibleJune 19, 202616 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Celiac disease and other small-intestinal enteropathies can cause secondary exocrine pancreatic insufficiency by reducing duodenal hormone signaling (especially cholecystokinin and secretin) that normally stimulates pancreatic enzyme and bicarbonate secretion.

laying out figure…
10 of 15 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that villous atrophy from celiac disease destroys or impairs duodenal enteroendocrine cells, lowering postprandial CCK and secretin release. This hormonal failure prevents normal pancreatic enzyme and bicarbonate secretion, producing a functional (secondary) exocrine pancreatic insufficiency rather than primary pancreatic damage.

Verified conclusion

Celiac disease and other small-intestinal enteropathies are established causes of secondary exocrine pancreatic insufficiency (EPI). This condition arises not from primary damage to the pancreas itself, but from a breakdown in the hormonal signaling cascade required for normal digestion.

Clinical evidence for secondary EPI

Research consistently identifies secondary EPI as a frequent complication of untreated or non-responsive celiac disease.

  • Prevalence: Studies, including systematic reviews and clinical observations, show that approximately 10% to 30% of celiac patients exhibit signs of EPI, often evidenced by low fecal elastase-1 (FE-1) levels (<200 μg/g).
  • Reversibility: A hallmark of this secondary form is its response to treatment. For many patients, pancreatic function improves or fully resolves following the adoption of a strict gluten-free diet, which allows the intestinal mucosa to heal and restores the enteropancreatic hormonal axis.
  • Pancreatic Health: Direct stimulation tests using exogenous hormones often yield normal enzyme output in these patients, confirming that the pancreas is structurally intact but functionally "under-stimulated" due to intestinal damage.

Mechanistic explanations

The mechanism driving this insufficiency is the "lazy pancreas" phenomenon, where the organ lacks the necessary triggers to secrete enzymes and bicarbonate.

  • Enteroendocrine Depletion: In healthy individuals, cholecystokinin (CCK) is released by I-cells and secretin by S-cells in the duodenal villi. In celiac disease, total villous atrophy (Marsh 3 lesions) destroys these cells or severely impairs their ability to sense nutrients.
  • Hormonal Signaling Failure: Physiological studies demonstrate that celiac patients have significantly lower postprandial plasma CCK and secretin levels compared to healthy controls.
  • Secretory Inhibition: Without secretin, pancreatic ductal cells fail to activate CFTR channels to secrete bicarbonate-rich fluid. Without CCK, pancreatic acinar cells are not signaled to release essential digestive enzymes like lipase, amylase, and trypsin. This dual signaling failure prevents the neutralization of gastric acid and the effective breakdown of macronutrients.

Bottom line

Celiac disease causes secondary EPI by destroying the duodenal cells responsible for producing CCK and secretin. This interrupts the vital signaling pathway to the pancreas, though the condition is often reversible through mucosal healing on a gluten-free diet.

References

  1. Pancreatic involvement in celiac disease — pmc.ncbi.nlm.nih.gov ↗
  2. Pancreatic endocrine and exocrine changes in celiac disease. — pmc.ncbi.nlm.nih.gov ↗
  3. Fecal elastase-1 concentration: an indirect test of exocrine pancreatic function and a marker of an enteropathy regardless of cause. — journals.lww.com ↗
  4. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease — frontiersin.org ↗
  5. Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring — mdpi.com ↗
  6. Protein hydrolysate-induced cholecystokinin secretion from enteroendocrine cells is indirectly mediated by the intestinal oligopeptide transporter PepT1. — pmc.ncbi.nlm.nih.gov ↗
  7. Pancreatic response to secretin-[-CCK-PZ in European and North African adults and children — semanticscholar.org ↗
  8. Activation of pancreatic acinar cells by very low concentrations of cholecystokinin: mechanism and implications for physiology and pathology. — linkinghub.elsevier.com ↗
  9. A comparison between secretin alone and sequential and simultaneous secretin and cholecystokinin administration in the assessment of pancreatic function 1 — pmc.ncbi.nlm.nih.gov ↗
  10. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. — pmc.ncbi.nlm.nih.gov ↗
  11. [Excretory pancreatic function: comparison of indirect function tests with the secretin-cholecystokinin test]. — thieme-connect.de ↗
  12. Exocrine Pancreatic Insufficiency and Pancreatitis Associated with Celiac Disease — pancreapedia.org ↗
  13. The broad spectrum of celiac disease and gluten sensitive enteropathy — pmc.ncbi.nlm.nih.gov ↗
  14. Role of CFTR in diabetes‐induced pancreatic ductal fluid and HCO3− secretion — physoc.onlinelibrary.wiley.com ↗
  15. Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth — frontiersin.org ↗
  16. The action of the C-terminal octapeptide of cholecystokinin and related peptides on pancreatic exocrine secretion — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→